[go: up one dir, main page]

MX2009007660A - Formulaciones de ciclodextrina. - Google Patents

Formulaciones de ciclodextrina.

Info

Publication number
MX2009007660A
MX2009007660A MX2009007660A MX2009007660A MX2009007660A MX 2009007660 A MX2009007660 A MX 2009007660A MX 2009007660 A MX2009007660 A MX 2009007660A MX 2009007660 A MX2009007660 A MX 2009007660A MX 2009007660 A MX2009007660 A MX 2009007660A
Authority
MX
Mexico
Prior art keywords
formulations
nose
gels
cyclodextrin formulations
cyclodextrins
Prior art date
Application number
MX2009007660A
Other languages
English (en)
Inventor
Peter Vitins
Marcel Langenauer
Original Assignee
Devirex Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devirex Ag filed Critical Devirex Ag
Publication of MX2009007660A publication Critical patent/MX2009007660A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

La presente invención está dirigida a varias formulaciones que comprenden una o más ciclodextrinas, dichas formulaciones siendo particularmente útiles para tratar o prevenir infecciones virales. En formas de realización específicas, las formulaciones comprenden geles de base no acuosa, spray para garganta y nariz, geles nasales, bálsamos labiales y emulsiones.
MX2009007660A 2007-01-17 2008-01-17 Formulaciones de ciclodextrina. MX2009007660A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88529307P 2007-01-17 2007-01-17
PCT/EP2008/000351 WO2008087034A2 (en) 2007-01-17 2008-01-17 Cyclodextrin formulations

Publications (1)

Publication Number Publication Date
MX2009007660A true MX2009007660A (es) 2009-11-18

Family

ID=39563399

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009007660A MX2009007660A (es) 2007-01-17 2008-01-17 Formulaciones de ciclodextrina.

Country Status (13)

Country Link
US (1) US20100111883A1 (es)
EP (1) EP2121027A2 (es)
JP (1) JP2010516646A (es)
KR (1) KR20090111328A (es)
CN (1) CN101631565A (es)
AU (1) AU2008207104A1 (es)
BR (1) BRPI0806633A2 (es)
CA (1) CA2675190A1 (es)
IL (1) IL199812A0 (es)
MX (1) MX2009007660A (es)
RU (1) RU2009127890A (es)
SG (1) SG177217A1 (es)
WO (1) WO2008087034A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236768B2 (en) 2008-10-03 2012-08-07 3B Pharmaceuticals, Inc. Topical antiviral formulations
SI2563374T1 (sl) 2010-07-08 2014-01-31 Devirex Ag Polietilenglikolni sestavki za nadzorovanje relapsa herpesa labialisa, herpesa genitalisa in herpesa zostra
EP2618810B1 (en) * 2010-09-21 2016-11-23 S & V Technologies GmbH Cosmetic composition
US10328152B2 (en) 2011-06-16 2019-06-25 Nayan Patel Method for stabilization and delivery of therapeutic molecules
WO2012174555A2 (en) * 2011-06-16 2012-12-20 Nayan Patel Composition and method for stabilization and delivery of therapeutic molecules
EP2782585B1 (en) 2011-11-23 2018-12-26 3B Pharmaceuticals, Inc. Antiviral formulations
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
EP2968083B1 (en) 2013-03-12 2021-09-22 Primal Therapies, Inc. Dental composition comprising chelator and base
DE102013021019B4 (de) * 2013-11-29 2016-04-14 Lutz Heuer Feste Massen, bestehend aus beta-Cyclodextrin und Polyethylenglykol, deren Mischungen mit Polyethylenglykolen, Verfahren zur Herstellung von Formkörpern und Verwendungen
EP3037082A1 (en) * 2014-12-22 2016-06-29 Spirig Pharma AG Sprayable cosmetic sunscreen composition
CA3031413A1 (en) * 2016-07-22 2018-01-25 Ecole Polytechnique Federale De Lausanne (Epfl) Virucidal compounds and uses thereof
BR112021004081A2 (pt) 2018-09-04 2021-05-25 Ecole Polytechnique Federale De Lausanne (Epfl) nanopartículas virucidas, composição farmacêutica, composição virucida, método de desinfecção e/ou esterilização, dispositivo e uso das nanopartículas virucidas
BE1027425B1 (fr) * 2019-07-01 2021-02-08 Aquilon Pharmaceuticals Composition inhalable comprenant de la cyclodextrine a utiliser dans le traitement d’inflammations nasales
CN115920084A (zh) * 2023-02-17 2023-04-07 武汉科技大学 一种羟甲香豆素环糊精包合物的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
BE1007402A5 (nl) * 1993-03-26 1995-06-06 Adir Nasale farmaceutische preparaten met progestagene stof.
EP0689438B1 (en) * 1993-03-26 2003-06-04 Franciscus Wilhelmus Henricus Maria Merkus Pharmaceutical compositions for intranasal administration of apomorphine
DE69636978T2 (de) * 1995-06-29 2007-09-06 Shiseido Co. Ltd. Wässrige zusammensetzung enthaltend einen cholesterinester-clathrat, diese enthaltendes kosmetikum und verfahren für ihre herstellung
JP3648330B2 (ja) * 1995-06-29 2005-05-18 株式会社資生堂 化粧料の製造方法、及び口紅用組成物の製造方法
US6596263B1 (en) * 1995-07-14 2003-07-22 Stc English Ideas, Inc. Cyclodextrin compositions
DE69719834T2 (de) * 1996-04-24 2003-11-20 Pfizer Inc., New York Dentalwerkstoffe enthaltend Cyclodextrine und phenolische Verbindungen
DE19627498A1 (de) * 1996-07-08 1998-01-15 Nat Starch Chem Invest Stärkehaltige Reinigungs- und Pflegemittel
CA2428189A1 (en) * 2000-11-15 2002-05-23 Mainde Chandrashekhar Pharmaceutival preparations comprising corticosteroids and antiinfective agents
US20030044356A1 (en) * 2001-04-20 2003-03-06 Jin Auh Composition for nasal solution sprays having effective component of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one)
US20030027833A1 (en) * 2001-05-07 2003-02-06 Cleary Gary W. Compositions and delivery systems for administration of a local anesthetic agent
WO2002094324A1 (en) * 2001-05-18 2002-11-28 Institute Of Materials Research & Engineering Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
WO2003080080A1 (en) * 2002-03-21 2003-10-02 Regents Of The University Of Minnesota Cyclodextrin compositions and methods of treating viral infections
US6958142B2 (en) * 2002-08-02 2005-10-25 Balance Pharmaceuticals, Inc. Nasal spray formulation and method
DE10253042A1 (de) * 2002-11-14 2004-06-03 Wacker-Chemie Gmbh Kosmetische Zubereitung enthaltend einen Komplex aus Cyclodextrin und Vitamin F
US20060024247A1 (en) * 2004-07-28 2006-02-02 Bioactives, Llc Oral care formulations comprising highly bioavailable Coenzyme Q-10 cyclodextrin complex
JP2006328039A (ja) * 2005-04-26 2006-12-07 Nippo Kagaku Kk 鳥インフルエンザウイルス不活化剤

Also Published As

Publication number Publication date
KR20090111328A (ko) 2009-10-26
WO2008087034A2 (en) 2008-07-24
WO2008087034A3 (en) 2009-01-29
CN101631565A (zh) 2010-01-20
EP2121027A2 (en) 2009-11-25
JP2010516646A (ja) 2010-05-20
AU2008207104A1 (en) 2008-07-24
IL199812A0 (en) 2010-04-15
SG177217A1 (en) 2012-01-30
BRPI0806633A2 (pt) 2011-09-06
RU2009127890A (ru) 2011-02-27
CA2675190A1 (en) 2008-07-24
US20100111883A1 (en) 2010-05-06

Similar Documents

Publication Publication Date Title
MX2009007660A (es) Formulaciones de ciclodextrina.
ATE481984T1 (de) Vakzine-peptid-kombinationen gegen katzenallergie
TN2009000398A1 (en) 5,6-dihydro-1h-pyridin-2-one compounds
EP2569330A4 (en) CHLOROTOXIN VARIANTS AND CONJUGATES AND METHOD OF USE THEREOF
EA201890315A1 (ru) Молекулы антител, связывающие cd22
DK2190473T3 (da) Peptid med reduceret dimerdannelse
GB2471806A (en) Compositions and methods for treating viral infections
MX2009006846A (es) Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias.
MX2018000147A (es) Moleculas de anticuerpo que se unen al grupo de diferenciacion 45 (cd45).
BR112012016749A2 (pt) "d-aminoácido para uso no tratamento de biofilmes"
CL2008001756A1 (es) Agente de arn de interferencia (iarn); composicion farmaceutica que lo comprende; y su uso para tratar procesos patologicos mediados al menos en parte por la expresion del canal de sodio epitelial alfa (alfa-enac)
EP2271401A4 (en) TOPICAL OR COSMETIC MICROSTROME GENERATING SYSTEMS AND METHOD FOR THEIR MANUFACTURE AND USE
MX2010006933A (es) Composiciones y metodos para reducir o prevenir la deshidratación de la piel.
CL2009000119A1 (es) Compuestos derivados de amino-bencimidazoles sustituidos; composicion farmaceutica; y su uso en el tratamiento del alzheimer.
EA201071248A1 (ru) Дизамещенные фталазиновые антагонисты пути hedgehog
EA201170288A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
MY161473A (en) Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
WO2008073982A3 (en) 5,6-dihydro-1h-pyridin-2-one compounds
CR11126A (es) Inhibicion de metastasis de tumor por anticuerpos anti neuropilina 2
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust
JO2795B1 (en) Immunoglobulins
WO2009137900A3 (en) Stabilization processes of cation radicals of phenothiazinic compounds, cosmeceutical formulations and methods for skin diseases and disturbances prevention
WO2011036169A3 (de) Mittel zur behandlung keratinischer fasern enthaltend dimethylsilanol hyaluronate und glycerin
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения
WO2011103028A3 (en) Compositions and methods for inhibiting mmset